Page 55 - GPD-3-4

Gene & Protein in Disease Immune checkpoint blocker and NK cell activation

NK-cell infiltration into solid tumors: A key limiting factor 1992;11(11):3887-3895.
for efficacious cancer immunotherapy. Cancer Discov. doi: 10.1002/j.1460-2075.1992.tb05481.x
2014;4(5):522-526.
46. Neel BG, Gu H, Pao L. The “Shp’ing news: SH2 domain-
doi: 10.1158/2159-8290.cd-13-0985 containing tyrosine phosphatases in cell signaling. Trends
35. Melaiu O, Lucarini V, Cifaldi L, Fruci D. Influence of the Biochem Sci. 2003;28(6):284-293.
tumor microenvironment on NK cell function in solid doi: 10.1016/s0968-0004(03)00091-4
tumors. Front Immunol. 2019;10:3038.
47. Han Y, Liu D, Li L. PD-1/PD-L1 pathway: Current researches
doi: 10.3389/fimmu.2019.03038 in cancer. Am J Cancer Res. 2020;10(3):727-742.
36. Blank CU, Haining WN, Held W, et al. Defining “T cell 48. Ahmadzadeh M, Johnson LA, Heemskerk B, et al. Tumor
exhaustion”. Nat Rev Immunol. 2019;19(11):665-674. antigen-specific CD8 T cells infiltrating the tumor express
doi: 10.1038/s41577-019-0221-9 high levels of PD-1 and are functionally impaired. Blood.
2009;114(8):1537-1544.
37. Philip M, Fairchild L, Sun L, et al. Chromatin states define
tumour-specific T cell dysfunction and reprogramming. doi: 10.1182/blood-2008-12-195792
Nature. 2017;545(7655):452-456. 49. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its
doi: 10.1038/nature22367 ligands in tolerance and immunity. Annu Rev Immunol.
2008;26:677-704.
38. Shim YJ, Khedraki R, Dhar J, et al. Early T cell infiltration is
modulated by programed cell death-1 protein and its ligand doi: 10.1146/annurev.immunol.26.021607.090331
(PD-1/PD-L1) interactions in murine kidney transplants. 50. Staron MM, Gray SM, Marshall HD, et al. The transcription
Kidney Int. 2020;98(4):897-905. factor FoxO1 sustains expression of the inhibitory receptor
doi: 10.1016/j.kint.2020.03.037 PD-1 and survival of antiviral CD8(+) T cells during chronic
infection. Immunity. 2014;41(5):802-814.
39. Habif G, Crinier A, André P, Vivier E, Narni-Mancinelli E.
Targeting natural killer cells in solid tumors. Cell Mol doi: 10.1016/j.immuni.2014.10.013
Immunol. 2019;16(5):415-422. 51. Morimoto Y, Kishida T, Kotani SI, Takayama K, Mazda O.
doi: 10.1038/s41423-019-0224-2 Interferon-β signal may up-regulate PD-L1 expression
through IRF9-dependent and independent pathways
40. Huang Q, Huang M, Meng F, Sun R. Activated pancreatic in lung cancer cells. Biochem Biophys Res Commun.
stellate cells inhibit NK cell function in the human pancreatic 2018;507(1-4):330-336.
cancer microenvironment. Cell Mol Immunol. 2019;1:87-89.
doi: 10.1016/j.bbrc.2018.11.035
doi: 10.1038/s41423-018-0014-2
52. Mathieu M, Cotta-Grand N, Daudelin JF, Thébault P,
41. Castriconi R, Dondero A, Bellora F, et al. Neuroblastoma- Labrecque N. Notch signaling regulates PD-1 expression
derived TGF-β1 modulates the chemokine receptor during CD8(+) T-cell activation. Immunol Cell Biol.
repertoire of human resting NK cells. J Immunol. 2013;91(1):82-88.
2013;190(10):5321-5328.
doi: 10.1038/icb.2012.53
doi: 10.4049/jimmunol.1202693
53. Kinter AL, Godbout EJ, McNally JP, et al. The common
42. Yoon SR, Kim TD, Choi I. Understanding of molecular gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce
mechanisms in natural killer cell therapy. Exp Mol Med. the expression of programmed death-1 and its ligands.
2015;47(2):e141. J Immunol. 2008;181(10):6738-6746.
doi: 10.1038/emm.2014.114 doi: 10.4049/jimmunol.181.10.6738
43. Robert C. A decade of immune-checkpoint inhibitors in 54. Oestreich KJ, Yoon H, Ahmed R, Boss JM. NFATc1 regulates
cancer therapy. Nat Commun. 2020;11(1):3801. PD-1 expression upon T cell activation. J Immunol.
doi: 10.1038/s41467-020-17670-y 2008;181(7):4832-4839.
44. Riella LV, Paterson AM, Sharpe AH, Chandraker A. Role of doi: 10.4049/jimmunol.181.7.4832
the PD-1 pathway in the immune response. Am J Transplant. 55. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The
2012;12(10):2575-2587. function of programmed cell death 1 and its ligands in
doi: 10.1111/j.1600-6143.2012.04224.x regulating autoimmunity and infection. Nat Immunol.
2007;8(3):239-245.
45. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression
of PD-1, a novel member of the immunoglobulin gene doi: 10.1038/ni1443
superfamily, upon programmed cell death. Embo J. 56. Yamazaki T, Akiba H, Iwai H, et al. Expression of

Volume 3 Issue 4 (2024) 7 doi: 10.36922/gpd.3804